<DOC>
	<DOCNO>NCT00083421</DOCNO>
	<brief_summary>The purpose study establish presence effect treatment ONO-2506PO patient Alzheimer 's Disease , base upon cognitive global scale .</brief_summary>
	<brief_title>Effects ONO-2506PO Patients With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable Alzheimer 's Disease use NINCDS/ADRDA criterion Standardized MMSE Score 13 24 point ( inclusive ) Modified Hachinski score equal less 4 Serious systemic disease may preclude survival study completion Other illness may include dementive feature</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>